Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
Ischemia–reperfusion (I/R) is a common pathological phenomenon that occurs in numerous organs and diseases. It generally results from secondary damage caused by the recovery of blood flow and reoxygenation, followed by ischemia of organ tissues, which is often accompanied by severe cellular damage a...
Main Authors: | Linxiang Zhou, Shangting Han, Jiayu Guo, Tao Qiu, Jiangqiao Zhou, Lei Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/22/3653 |
Similar Items
-
γ-Glutamylcysteine Exerts Neuroprotection Effects against Cerebral Ischemia/Reperfusion Injury through Inhibiting Lipid Peroxidation and Ferroptosis
by: Ruyi Zhang, et al.
Published: (2022-08-01) -
Current Status and Prospects of Research on Ischemia-Reperfusion Injury and Ferroptosis
by: Lin Hou, et al.
Published: (2022-08-01) -
Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
by: Yihang Pan, et al.
Published: (2022-11-01) -
Berberine protects cardiac cells against ferroptosis
by: Kun-Ta Yang, et al.
Published: (2022-01-01) -
Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review
by: Cuihua Liu, et al.
Published: (2023-03-01)